Please assess the completion status of the following clinical trial:

Trial Title: Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* consecutive patients scheduled for the elective off-pump CABG surgery~Exclusion Criteria:~* prior statin use~* previous episodes of atrial fibrillation~* impaired renal function with serum creatinine \>2mg/dL~* serum aspartate aminotransferase or alanine aminotransferase concentrations more than 3 times the upper limit of normal~* a malignancy or inflammatory disease

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Atorvastatin group
- 2 (Type: NO_INTERVENTION): Control group

Based on this trial design, predict the completion outcome and termination type (if applicable).